Quang X. Pham's Planned Sale of Common Shares in Cadrenal Therapeutics, Inc.

Quang X. Pham, an officer of Cadrenal Therapeutics, Inc., has filed a notice of planned sale of 1,129 common shares acquired as Founders Shares on January 25, 2022. The sale is scheduled for October 24, 2025, with an aggregate market value of $15,840.87. The shares are listed on NASDAQ, and the sale will be facilitated by Merrill Lynch. In the past three months, Pham has sold a significant number of shares, totaling 18,000 units, with gross proceeds exceeding $250,000. The transactions occurred between August 27, 2025, and October 13, 2025. The filing indicates that Pham has been actively managing his holdings in the company.